EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/11/2024
Back to search
Official data from USPTO
INTEGRATED TRIAL SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INTEGRATED TRIAL SOLUTIONS
ST13
US500000090544095Class
35
Filing
90544095
Registration
6668870
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/17/2024
Trademark type
Word
Nice classes
35
Filing date
02/24/2021
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
12/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
02/01/2021
First use in commerce
02/01/2021
Drawing code
4
Owner type
03
Owner location
AUSTIN, TX, US
Examiner
WU, KRISTEN ZAHNOW
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ELLIGO HEALTH RESEARCH, INC.
CLINEDGE, LLC
Representatives
Theresa D. Koller Cline Williams
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsproviding business information management services; Providing rapid start-up and operational business development assistance to clinical research sites of others; conducting business feasibility studies; providing business development services to a network of investigation sites and providing independent review of clinical trials for business purposes through a network of investigational sites; business consulting and management in the field of clinical trialsproviding third parties business information and advice for selecting investigational sitesmanaging patient study proceduresmanaging data workflows
Publications
History of USPTO decisions and trademark events.
31 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/20/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/20/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/20/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/20/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/20/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/08/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/01/2022
ALIE
ASSIGNED TO LIE
01/25/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/24/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/24/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/03/2021
GNRT
NON-FINAL ACTION E-MAILED
08/03/2021
CNRT
NON-FINAL ACTION WRITTEN
08/03/2021
DOCK
ASSIGNED TO EXAMINER
07/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/25/2021
NWAP
NEW APPLICATION ENTERED
02/27/2021
Continuous trademark protection
Get notified about every new filing that threatens INTEGRATED TRIAL SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.